Compounds > pyridinolcarbamate
Page last updated: 2024-11-03

pyridinolcarbamate and Cholera Infantum

pyridinolcarbamate has been researched along with Cholera Infantum in 2 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schettler, G1
Mishima, Y1
Kamiya, K1
Sakaguchi, S1
Kusaba, A1
Sakuma, A1

Trials

1 trial available for pyridinolcarbamate and Cholera Infantum

ArticleYear
A multiclinic double-blind trial of pyridinolcarbamate and inositol niacinate in ischemic ulcer due to chronic arterial occlusion.
    Angiology, 1977, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Arterial Occlusive Diseases; Arteriosclerosis; Aspart

1977

Other Studies

1 other study available for pyridinolcarbamate and Cholera Infantum

ArticleYear
[Undesirable effects of hypolipemic drugs].
    La Clinica terapeutica, 1980, Mar-15, Volume: 92, Issue:5

    Topics: Adult; Arrhythmias, Cardiac; Avitaminosis; Biliary Tract Diseases; Cholestyramine Resin; Clofibrate;

1980